序号 | 法律法规名称 | 生效日期 | 颁布单位 | 法规分类 | 备注 | 其他 |
1 | 1.Active Pharmaceutical Ingredients (Second Edition) - Revision to Bulk Pharmaceutical Chemicals
活性药物成分(第二版)---对散装药用化学品的修订 | 2007 | ISPE | Baseline® Guides | 有 | |
2 | 2.Oral Solid Dosage Forms (Second Edition)
口服固体制剂(第二版) | 2009 | ISPE | Baseline® Guides | 有 | |
3 | 3.Sterile Product Manufacturing Facilities (Second Edition)
无菌药品生产设施(第二版) | 2011 | ISPE | Baseline® Guides | 有 | |
4 | 4.Water and Steam Systems (Second Edition)
水和蒸汽系统(第二版) | 2011 | ISPE | Baseline® Guides | 有 | |
5 | 5.Commissioning and Qualification
调试与确认 | 2001 | ISPE | Baseline® Guides | 有 | |
6 | 6.Biopharmaceutical Manufacturing Facilities (Second Edition)
生物药品生产设施(第二版) | 2003 | ISPE | Baseline® Guides | 有 | |
7 | 7.Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP)
基于风险的药品生产(风险MAPP) | 2010 | ISPE | Baseline® Guides | 有 | |
8 | GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized Systems
GAMP 5: 保证GXP计算机系统符合性的基于风险的方法 | 2008 | ISPE | GAMP® | 有 | |
9 | A Risk-Based Approach to Calibration Management (Second Edition)
基于风险的校验管理方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
10 | A Risk-Based Approach to GxP Compliant Laboratory Computerized Systems (Second Edition)
基于风险的GXP符合性实验室计算机化系统方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
11 | A Risk-Based Approach to GxP Process Control Systems (Second Edition)
基于风险的GXP过程控制系统(第二版) | | ISPE | GAMP® Good Practice Guides | 缺 | |
12 | A Risk-Based Approach to Operation of GxP Computerized Systems
GXP 计算机化系统操作的风险管理方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
13 | A Risk-Based Approach to Regulated Mobile Applications
基于风险的移动APP管理方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
14 | A Risk-Based Approach to Testing of GxP Systems (Second Edition)
基于风险的GXP系统检测方法(第二版) | | ISPE | GAMP® Good Practice Guides | 缺 | |
15 | Electronic Data Archiving
电子数据归档 | | ISPE | GAMP® Good Practice Guides | 缺 | |
16 | Global Information Systems
全球信息系统 | | ISPE | GAMP® Good Practice Guides | 缺 | |
17 | IT Infrastructure Control and Compliance
IT基础设施控制和符合性 | | ISPE | GAMP® Good Practice Guides | 缺 | |
18 | Legacy Systems
遗留系统 | | ISPE | GAMP® Good Practice Guides | 缺 | |
19 | Manufacturing Execution Systems – A Strategic and Program Management Approach
生产执行系统—策略和编程管理方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
20 | Risk-Based Approach to Electronic Records and Signatures
基于风险的电子记录和签名方法 | | ISPE | GAMP® Good Practice Guides | 缺 | |
21 | Applied Risk Management for Commissioning and Qualification
调试和确认中的风险管理 | | ISPE | ISPE Good Practice Guides | 缺 | |
22 | Approaches to Commissioning and Qualification of Pharmaceutical Water and Steam Systems (Second Edition)
制药用水和蒸汽系统调试和确认方法(第二版) | 2008 | ISPE | ISPE Good Practice Guides | 有 | |
23 | Assessing the Particulate Containment Performance of Pharmaceutical Equipment (Second Edition)
制药设备颗粒密闭性能的评估(第二版) | | ISPE | ISPE Good Practice Guides | 缺 | |
24 | Booklet Labels
书册标签 | | ISPE | ISPE Good Practice Guides | 缺 | |
25 | Clinical Supply Systems
临床补给系统 | | ISPE | ISPE Good Practice Guides | 缺 | |
26 | Cold Chain Management
冷链管理 | | ISPE | ISPE Good Practice Guides | 缺 | |
27 | Comparator Management
对照组管理 | | ISPE | ISPE Good Practice Guides | 缺 | |
28 | Development of Investigational Therapeutic Biological Products
临床前治疗用生物产品开发 | | ISPE | ISPE Good Practice Guides | 缺 | |
29 | Good Engineering Practice优良工程规范 | 2008 | ISPE | ISPE Good Practice Guides | 有 | |
30 | Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs)
协调非临床前药品的定义和使用 | | ISPE | ISPE Good Practice Guides | 缺 | |
31 | HVAC | | ISPE | ISPE Good Practice Guides | 有 | |
32 | Interactive Response Technology
互动反馈技术 | | ISPE | ISPE Good Practice Guides | 缺 | |
33 | Maintenance
维护 | | ISPE | ISPE Good Practice Guides | 缺 | |
34 | Ozone Sanitization of Pharmaceutical Water Systems
制药用水系统的臭氧消毒 | | ISPE | ISPE Good Practice Guides | 缺 | |
35 | Packaging, Labeling, and Warehousing Facilities
包装、贴标和仓储设施 | | ISPE | ISPE Good Practice Guides | 缺 | |
36 | Process Gases
工艺用气 | | ISPE | ISPE Good Practice Guides | 缺 | |
37 | Project Management for the Pharmaceutical Industry
制药行业的项目管理 | | ISPE | ISPE Good Practice Guides | 缺 | |
38 | Quality Laboratory Facilities
质量实验室设施 | | ISPE | ISPE Good Practice Guides | 缺 | |
39 | Technology Transfer (Second Edition)
技术转移(第二版) | 2003 | ISPE | ISPE Good Practice Guides | 有 | |
40 | Biopharmaceutical Process Development and Manufacturing
生物药品工艺开发与生产 | | ISPE | ISPE Guides | 缺 | |
41 | Science and Risk-Based Approach for the Delivery of Facilities, Systems, and Equipment
基于风险的设施、系统和设备传送科学方法 | | ISPE | ISPE Guides | 缺 | |
42 | 1.Validation of Moist Heat Sterilization Processes: Cycle Design, Development, Qualification and Ongoing Control Revised 2007 (Published 1980)
湿热灭菌工艺验证:循环设计、研发、确认和持续控制,修订2007 | 2007 | PDA | PDA TR | 有 | |
43 | 3.Validation of Dry Heat Processes Used for Depyrogenation and Sterilization Revised 2013 (Published 1981) 01003 43506
用于除热源和灭菌的干热工艺验证,修订2013 | 2013 | PDA | PDA TR | 有 | |
44 | 4,Design Concepts for the Validation of Water-for-Injection Systems 1983
注射用水系统验证的设计概念,1983 | 1983 | PDA | PDA TR | 有 | |
45 | 5.Sterile Pharmaceutical Packaging: Compatibility and Stability 1984无菌制剂包装:相容性和稳定性,1984 | 1984 | PDA | PDA TR | 有 | |
46 | 7.Depyrogenation 1985
除热源,1985 | 1985 | PDA | PDA TR | 有 | |
47 | 9.Review of Commercially Available Particulate Measurement Systems 1988
商业可采购的颗粒物检测系统审核,1988 | 1988 | PDA | PDA TR | 有 | |
48 | 10. Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers 1988
蛋白质和多肽注射制剂:稳定性和稳定剂,1988 | 1988 | PDA | PDA TR | 缺 | |
49 | 11. Sterilization of Parenterals by Gamma Radiation 1988
静脉注射伽马辐射灭菌,1988 | 1988 | PDA | PDA TR | 有 | |
50 | 12. Siliconization of Parenteral Drug Packaging Components 1988
静脉注射剂药品包装组分硅化处理,1988 | 1988 | PDA | PDA TR | 有 | |
51 | 13. Fundamentals of an Environmental Monitoring Program Revised 2014 (Published 1990)
环境监测计划原则,修订2014 | 2014 | PDA | PDA TR | 有 | |
52 | 14. Validation of Column-Based Chromatography Processes for the Purification of Proteins Revised 2008 (Published 1992)
蛋白纯化用柱色谱工艺验证,修订2008 | 2008 | PDA | PDA TR | 有 | |
53 | 15. Validation of Tangential Flow Filtration in Biopharmaceutical Applications Revised 2009 (Published 1992)
生物制药用正切流过滤验证,修订2009 | 2009 | PDA | PDA TR | 有 | |
54 | 16. Effect of Gamma Irradiation on Elastomeric Closures 1992
人造橡胶塞伽马辐射效应,1992 | 1992 | PDA | PDA TR | 有 | |
55 | 17. Current Practices in the Validation of Aseptic Processing -- 1992 1993
无菌工艺验证现行规范,1992,1993 | 1993 | PDA | PDA TR | 缺 | |
56 | 18. Report on the Validation of Computer-Related Systems 1995
计算机相关系统验证报告,1995 | 1995 | PDA | PDA TR | 缺 | |
57 | 19. Rapid/Automated ID Methods Survey 1990
快速/自动ID方法调查,1990 | 1990 | PDA | PDA TR | 有 | |
58 | 20. Report on Survey of Current Industry Gowning Practices 1990
行业现行更衣规范调查报告,1990 | 1990 | PDA | PDA TR | 缺 | |
59 | 21. Bioburden Recovery Validation 1990
生物负载回收率验证,1990 | 1990 | PDA | PDA TR | 有 | |
60 | 22. Process Simulation for Aseptically Filled Products Revised 2011 (Published 1996)
无菌灌装药品工艺模拟,修订2011 | 2011 | PDA | PDA TR | 有 | |
61 | 23. Industry Survey on Current Sterile Filtration Practices 1996
现行无菌过滤实践行业调查,1996 | 1996 | PDA | PDA TR | 缺 | |
62 | 24. Current Practices in the Validation of Aseptic Processing – 1996 1996
无菌工艺验证现行规范,1996 | 1996 | PDA | PDA TR | 有 | |
63 | 25. Blend Uniformity Analysis: Validation and In-Process Testing 1997
混合均一性分析:验证和中控测试,1997 | 1997 | PDA | PDA TR | 有 | |
64 | 26. Sterilizing Filtration of Liquids Revised 2008 (Published 1998)
液体无菌过滤,修订2008 | 2008 | PDA | PDA TR | 有 | |
65 | 27. Pharmaceutical Package Integrity 1998
药品包装完整性,1998 | 1998 | PDA | PDA TR | 有 | |
66 | 28. Process Simulation Testing for Sterile Bulk Pharmaceutical Chemicals Revised 2006 (Published 1998)
无菌散装药用化学物工艺模拟测试,修订2006 | 2006 | PDA | PDA TR | 有 | |
67 | 29. Points to Consider for Cleaning Validation Revised 2012 (Published 1998)
清洁验证的考虑要点,修订2012 | 2012 | PDA | PDA TR | 有 | |
68 | 30. Parametric Release of Pharmaceuticals and Medical Device Products Terminally Sterilized by Moist Heat Revised 2012 (Published 1999)
最终湿热灭菌的药物和医疗器械参数放行,修订2012 | 2012 | PDA | PDA TR | 有 | |
69 | 31. Validation and Qualification of Computerized Laboratory Data Acquisition Systems 1999
计算机化实验室数据获取系统验证和确认,1999 | 1999 | PDA | PDA TR | 有 | |
70 | 32. Auditing of Suppliers Providing Computer Products and Services for Regulated Pharmaceutical Operations Revised 2004 (Published 1999)
提供受法规管理的药物操作用计算机产品和服务的供应商审计,修订2004 | 2004 | PDA | PDA TR | 缺 | |
71 | 33. Evaluation, Validation and Implementation of Alternative and Rapid Microbiological Methods Revised 2013 (Published 2000)
替代性和快速微生物方法的评估、验证和实施,修订2013 | 2013 | PDA | PDA TR | 有 | |
72 | 34. Design and Validation of Isolate Systems for the Manufacturing and Testing of Health Care Products 2001保健药品的生产和检测分离系统的设计和验证,2001 | 2001 | PDA | PDA TR | 有 | |
73 | 35. A Proposed Training Model for the Microbiological Function in the Pharmaceutical Industry 2001
制药行业微生物功能培训模式建议,2001
| 2001 | PDA | PDA TR | 缺 | |
74 | 36. Current Practices in the Validation of Aseptic Processing – 2001 2002
无菌工艺验证的现行规范--2001,2002
| 2002 | PDA | PDA TR | 有 | |
75 | 38. Manufacturing Chromatography Systems Post-Approval Changes: (ChromPAC):Chemistry, Manufacturing and Controls Documentation 2006
批准后生产用色谱系统:研发、生产和控制文件,2006 | 2006 | PDA | PDA TR | 有 | |
76 | 39. Guidance for Temperature-Controlled Medicinal Products: Maintaining the Quality of Temperature-Sensitive Medicinal Products through the Transportation Environment 2007
温度受控药物指南:通过运输环境来维护对温度敏感的药物的质量,2007 | 2007 | PDA | PDA TR | 有 | |
77 | 40. Sterilization Filtration of Gases 2005
气体的无菌过滤,2005 | 2005 | PDA | PDA TR | 有 | |
78 | 41. Virus Filtration 2008
病毒过滤,2008 | 2008 | PDA | PDA TR | 有 | |
79 | 42. Process Validation of Protein Manufacturing 2005
蛋白质生产的工艺验证,2005 | 2005 | PDA | PDA TR | 有 | |
80 | 43. Identification and Classification of Nonconformities in Molded and Tubular Glass Containers for Pharmaceutical Manufacturing Revised 2013 (Published 2007)
药物生产用模型制备和管式玻璃容器的识别和分类,修订2013
| 2013 | PDA | PDA TR | 缺 | |
81 | 44. Quality Risk Management for Aseptic Processes 2008
无菌工艺的质量风险管理,2008 | 2008 | PDA | PDA TR | 有 | |
82 | 45. Filtration of Liquids Using Cellulose-Based Depth Filters 2008
使用纤维素基础深层过滤器的液体过滤,2008 | 2008 | PDA | PDA TR | 缺 | |
83 | 46. Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User 2009
最终里程:给最终用户的药物优良销售规范指南,2009 | 2009 | PDA | PDA TR | 缺 | |
84 | 47. Preparation of Virus Spikes Used for Virus Clearance Studies 2010
用于病毒清除研究的病毒加标样制备,2010 | 2010 | PDA | PDA TR | 缺 | |
85 | 48. Moist Heat Sterilizer Systems: Design, Commissioning, Operation, Qualification and Maintenance 2010
湿热灭菌系统:设计、调试、运行、确认和维护,2010 | 2010 | PDA | PDA TR | 有 | |
86 | 49. Points to Consider for Biotechnology Cleaning Validation 2010
生物制品清洁验证考虑要点,2010
| 2010 | PDA | PDA TR | 有 | |
87 | 50. Alternative Methods for Mycoplasma Testing 2010
支原体测试替代性方法,2010 | 2010 | PDA | PDA TR | 缺 | |
88 | 51. Biological Indicators for Gas and Vapor-Phase Decontamination Processes: Specification, Manufacture, Control and Use 2010
气体和蒸汽相除污染工艺生物指示剂:质量标准、生产、控制和使用,2010
| 2010 | PDA | PDA TR | 有 | |
89 | 52. Guidance Good Distribution Practices for the Pharmaceutical Supply Chain 2011
药品供应链优良销售规范指南,2011 | 2011 | PDA | PDA TR | 缺 | |
90 | 53. Guidance for Industry: Stability Testing to Support Distribution of New Drug Products 2011
行业指南:支持新药销售的稳定性测试,2011 | 2011 | PDA | PDA TR | 缺 | |
91 | 54. Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations 2012
药品和生物制品生产操作的质量风险管理实施,2012
| 2012 | PDA | PDA TR | 有 | |
92 | 54-2. Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operation: Annex 1: Case Study Examples for Quality Risk Management in Packaging and Labeling 2013
药品和生物制品生产操作的质量风险管理实施,附录1:包装和标识中的质量风险管理案例研究,2013 | 2013 | PDA | PDA TR | 缺 | |
93 | 54-3. Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations Annex 2: Case Studies in the Manufacturing of Pharmaceutical Drug Products 2013
药品和生物制品生产操作的质量风险管理实施,附录2:药品生产中的质量风险管理案例研究,2013
| 2013 | PDA | PDA TR | 缺 | |
94 | 54-4. Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations Annex 3: Case Studies in the Manufacturing of Biotechnological Bulk Drug Substances 2015
药品和生物制品生产操作的质量风险管理实施,附录3:生物散装药用物质生产中的质量风险管理案例研究,2013
| 2013 | PDA | PDA TR | 缺 | |
95 | 55. Detection and Mitigation of 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole Taints and Odors in the Pharmaceutical and Consumer Healthcare Industries 2012
药物和保健行业中2,4,6-三溴苯甲醚和2,4,6-三氯苯甲醚污染和气味的检测和移除,2012 | 2012 | PDA | PDA TR | 缺 | |
96 | 56. Application of Phase-Appropriate Quality Systems and CGMP to the Development of Therapeutic Protein Drug Substance 2012
治疗用蛋白质药用物质研发中与阶段相适当的质量体系和CGMP应用,2012 | 2012 | PDA | PDA TR | 缺 | |
97 | 57. Analytical Method Validation and Transfer for Biotechnology Products 2012
生物制品的分析方法验证和转移,2012 | 2012 | PDA | PDA TR | 缺 | |
98 | 58. Risk Management for Temperature-Controlled Distribution 2012
温度受控销售风险管理,2012
| 2012 | PDA | PDA TR | 缺 | |
99 | 59. Utilization of Statistical Methods for Production Monitoring 2012
生产监测用统计学方法使用,2012
| 2012 | PDA | PDA TR | 有 | |
100 | 60. Process Validation: A Lifecycle Approach 2013
工艺验证:生命周期方法,2013 | 2013 | PDA | PDA TR | 有 | |
101 | 61. Steam In Place 2013
就地蒸汽,2013 | 2013 | PDA | PDA TR | 有 | |
102 | 62. Recommended Practices for Manual Aseptic Processes 2013
人工无菌工艺规范建议,2013 | 2013 | PDA | PDA TR | 有 | |
103 | 63. Quality Requirements for the Extemporaneous Preparation of Clinical Trial 2013
临床试验临时制备药物的质量要求,2013 | 2013 | PDA | PDA TR | 缺 | |
104 | 64. Active Temperature-Controlled Systems: Qualification Guidance 2013
在用温度控制系统:确认指南,2013 | 2013 | PDA | PDA TR | 缺 | |
105 | 65. Technology Transfer 2014
技术转移,2014 | 2014 | PDA | PDA TR | 有 | |
106 | 66. Application of Single-Use Systems in Pharmaceutical Manufacturing 2014
药物生产中单次使用系统的应用,2014 | 2014 | PDA | PDA TR | 缺 | |
107 | 67. Exclusion of Objectionable Microorganisms from Nonsterile Pharmaceuticals, Medical Devices, and Cosmetics 2014
非无菌药物、医疗器械和化妆品中致病菌排除,2014 | 2014 | PDA | PDA TR | 缺 | |
108 | 68. Risk-Based Approach for Prevention and Management of Drug Shortages 2014
基于风险的药品存贮预防和管理,2014 | 2014 | PDA | PDA TR | 缺 | |
109 | Product Quality Lifecycle Implementation® (PQLI®) Guide: Overview of Product Design, Development and Realization: A Science- and Risk-Based Approach to Implementation
药品质量生命周期实施指南(PQLI):产品设计、开发及实践的综述-一种科学的基于风险的实施方法 | | ISPE | PQLI Guides | | |
110 | Product Quality Lifecycle Implementation® (PQLI®) from Concept to Continual Improvement
Part 1: Product Realization using QbD, Concepts and Principles
从概念到持续改进的药品质量生命周期实施(PQLI)第一部分:利用质量源于设计(QbD),概念和原则实现产品 | | ISPE | PQLI Guides | | |
111 | Product Quality Lifecycle Implementation® (PQLI®) from Concept to Continual Improvement
Part 2: Product Realization using QbD, Illustrative Example
从概念到持续改进的药品质量生命周期实施(PQLI)第二部分:利用质量源于设计(QbD),实例解说实现产品 | | ISPE | PQLI Guides | | |
112 | Product Quality Lifecycle Implementation® (PQLI®) from Concept to Continual Improvement
Part 3: Change Management System as a Key Element of a Pharmaceutical Quality System
从概念到持续改进的药品质量生命周期实施(PQLI)第三部分:药品质量体系关键要素-变更管理 | | ISPE | PQLI Guides | | |
113 | Product Quality Lifecycle Implementation® (PQLI®) from Concept to Continual Improvement
Part 4: Process Performance and Product Quality Monitoring System (PP&PQMS)
从概念到持续改进的药品质量生命周期实施(PQLI)第四部分:工艺性能和药品质量监测体系(PP&PQMS) | | ISPE | PQLI Guides | | |
114 | Q1A(R2): Stability Testing of New Drug Substances and Products (Second Revision)新原料药和制剂的稳定性试验(第二版) | | ICH | Quality | 有 | |
115 | Q1B: Photostability Testing of New Drug Substances and Products新原料药和制剂的光稳定性试验 | | ICH | Quality | 有 | |
116 | Q1C: Stability Testing for New Dosage Forms新制剂的稳定性试验 | | ICH | Quality | 有 | |
117 | Q1D: Bracketing and Matrixing Designs for Stability Testing of Drug Substances and Drug Products原料药和制剂稳定性试验的交叉和矩阵设计 | | ICH | Quality | 有 | |
118 | Q1E: Evaluation of Stability Data对稳定性数据的评估处理 | | ICH | Quality | 有 | |
119 | Q1F: Stability Data Package for Registration Applications in Climatic Zones III and IV 在气候带III和IV,药物注册申请所提供的稳定性数据 | | ICH | Quality | 有 | |
120 | Q2A: Text on Validation of Analytical Procedures分析程序的验证 | | ICH | Quality | 有 | |
121 | Q2B: Validation of Analytical Procedures: Methodology分析程序的验证:方法学 | | ICH | Quality | 有 | |
122 | Q3A(R): Impurities in New Drug Substances (Revised Guideline)新原料药中的杂质(修订版) | | ICH | Quality | 有 | |
123 | Q3B(R): Impurities in New Drug Products (Revised Guideline)新制剂中的杂质(修订版) | | ICH | Quality | 有 | |
124 | Q3C: Impurities: Guideline for Residual Solvents杂质:残留溶剂指南 | | ICH | Quality | 有 | |
125 | Q3C(M): Impurities: Guideline for Residual Solvents (Maintenance)杂质:残留溶剂指南(修改内容) | | ICH | Quality | 有 | |
126 | Q4: Pharmacopoeias药典 | | ICH | Quality | 有 | |
127 | Q4A: Pharmacopoeial Harmonisation 药典的协调 | | ICH | Quality | 有 | |
128 | Q4B: Regulatory Acceptance of Pharmacopoeial Interchangeability药典互替在法规上的可接受性 | | ICH | Quality | 有 | |
129 | Q5A: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin来源于人或者动物细胞系的生物技术产品的病毒安全性评估 | | ICH | Quality | 有 | |
130 | Q5B: Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products生物技术产品的质量:源于重组DNA的蛋白质产品的生产中所用的细胞中的表达构建分析 | | ICH | Quality | 有 | |
131 | Q5C: Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products生物技术产品的质量:生物技术/生物产品的稳定性试验 | | ICH | Quality | 有 | |
132 | Q5D: Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products用于生产生物技术/生物产品的细胞底物的起源和特征描述 | | ICH | Quality | 有 | |
133 | Q5E: Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process基于不同生产工艺的生物技术产品/生物产品的可比较性 | | ICH | Quality | 有 | |
134 | Q6: Specifications for New Drug Substances and Products新原料药和制剂的质量规格 | | ICH | Quality | 有 | |
135 | Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances质量规格:新原料药和新制剂的检验程序和可接收标准:化学物质 | | ICH | Quality | 有 | |
136 | Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products质量规格:生物技术/生物产品的检验程序和可接收标准 | | ICH | Quality | 有 | |
137 | Q7: Good Manufacturing Practices for Pharmaceutical Ingredients活性药物成份的GMP | | ICH | Quality | 有 | |
138 | Q7A: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients活性药物成份的GMP指南 | | ICH | Quality | 有 | |
139 | Q8: Pharmaceutical Development药物研发 | | ICH | Quality | 有 | |
140 | Q9: Quality Risk Management质量风险管理 | | ICH | Quality | 有 | |
141 | Q10: Pharmaceutical Quality System
药物质量体系 | | ICH | Quality | 有 | |
142 | Q11 :Developmentand manufacture of drug substances原料药的开发与制造 | | ICH | Quality | 有 | |
143 | Basic Requirements for Medicinal Products
药品的基本需求 | | EU | Good manufacturing practice (GMP) Guidelines. | 有 | |
144 | Basic Requirements for Active Substances used as Starting Materials
作为起始物料的活性物质的基本要求 | | EU | Good manufacturing practice (GMP) Guidelines. | 有 | |
145 | Site Master File
工厂主文件 | | EU | GMP related documents | 有 | |
146 | Q9 Quality Risk Management
Q9 质量风险管理 | | EU | GMP related documents | 有 | |
147 | MRA Batch Certificate
MRA批证书 | | EU | GMP related documents | 有 | |
148 | Template for the 'written confirmation' for active substances exported to the European Union for medicinal products for human use
用于人用药品的活性物质出口到欧盟的“确认证书”模板 | | EU | GMP related documents | 有 | |
149 | 1、Manufacture of Sterile Medicinal Products
无菌药品的生产 | | EU | Annexes | 有 | |
150 | 2、Manufacture of Biological active substances and Medicinal Products for Human Use
人用生物药品的生产 | | EU | Annexes | 有 | |
151 | 3、Manufacture of Radiopharmaceuticals
放射性药物的生产 | | EU | Annexes | 有 | |
152 | 4、Manufacture of Veterinary Medicinal Products other than Immunological Veterinary Medicinal Products
非免疫动物药品的生产 | | EU | Annexes | 有 | |
153 | 5、Manufacture of Immunological Veterinary Medicinal Products
免疫动物药品的生产 | | EU | Annexes | 有 | |
154 | 6、Manufacture of Medicinal Gases
医用气体的生产 | | EU | Annexes | 有 | |
155 | 7、Manufacture of Herbal Medicinal Products
草本药品的生产 | | EU | Annexes | 有 | |
156 | 8、Sampling of Starting and Packaging Materials
原材料和包装材料的取样 | | EU | Annexes | 有 | |
157 | 9、Manufacture of Liquids, Creams and Ointments
液体、乳剂、膏剂的生产 | | EU | Annexes | 有 | |
158 | 10、Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation
压力计量喷雾状吸入式式药剂的生产 | | EU | Annexes | 有 | |
159 | 11、Computerised Systems (revision January 2011)
计算机系统 | | EU | Annexes | 有 | |
160 | 12、Use of Ionising Radiation in the Manufacture of Medicinal Products
药品生产过程中电离辐射的应用 | | EU | Annexes | 有 | |
161 | 13、Manufacture of Investigational Medicinal Products
研究用药品的生产 | | EU | Annexes | 有 | |
162 | 14、Manufacture of Products derived from Human Blood or Human Plasma
来自于人体血液或血浆的药品生产 | | EU | Annexes | 有 | |
163 | 15、Qualification and validation
确认和验证 | | EU | Annexes | 有 | |
164 | 16、Certification by a Qualified person and Batch Release
资质人员签发证书和批放行 | | EU | Annexes | 有 | |
165 | 17、Parametric Release
参数放行 | | EU | Annexes | 有 | |
166 | 19、Reference and Retention Samples
对照品和留样 | | EU | Annexes | 有 | |
167 | Guidelines on Good Distribution Practice of Medicinal Products for human Use | | EU | GDP | 有 | |
168 | 21CFR210Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General | | FDA | 21 Code of Federal Regulations | 有 | |
169 | VALIDATION OF ASEPTIC PROCESSES | 2011.01.01 | PIC/S | Guidance documents | 有 | PE 008-4 |
170 | SITE MASTER FILE FOR SOURCE PLASMA ESTABLISHMENTS | 2007.09.25 | PIC/S | Site Master Files | 有 | PE 009-11 |
171 | GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS | 2007.09.25 | PIC/S | Guidance documents | 有 | PE 010-4 |
172 | GUIDANCE ON PARAMETRIC RELEASE | 2007.09.25 | PIC/S | Guidance documents | 有 | PE 011-1 |
173 | QA DISTRIBUTION ACTIVITIES FOR APIs - MAY 2010 | 2011.03.24 | PIC/S | Q&A Documents | 有 | PI 002-3 |
174 | GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS (PE 010-4) | 2014.03.01 | PIC/S | Guidance documents | 有 | PI 005-3 |
175 | ISOLATORS USED FOR ASEPTIC PROCESSING AND STERILITY TESTING | 2007.09.25 | PIC/S | Guidance documents | 有 | PI 006-3 |
176 | JOINT PIC/S-EMA CONCEPT PAPER ON THE REVISION OF ANNEX 1 | 2015.02.05 | PIC/S | PIC/S GMP Guide | 有 | PI 007-6 |
177 | PARTICIPATING AUTHORITIES & PARTNERS & (PRE)-APPLICANTS | 2015.01.09 | PIC/S | Inspectorates | 有 | PI 008-3 |
178 | AIDE MEMOIRE ON GMP PARTICULARITIES FOR CLINICAL TRIAL PRODUCTS | 2007.09.25 | PIC/S | Aide-Memoires | 有 | PI 009-3 |
179 | QA ON TRACEABILITY OF MEDICINAL GASES | 2012.12.18 | PIC/S | Q&A Documents | 有 | PI 010-4 |
180 | PIC/S GMP GUIDE | 2014.03.01 | PIC/S | PIC/S GMP Guide | 有 | PI 011-3 |
181 | PIC/S Guide to Good Distribution Practice (GDP) for Medicinal Products | 2014.06.01 | PIC/S | Guidance documents | 有 | PI 012-3 |
182 | QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES | 2007.09.25 | PIC/S | Inspectorates | 有 | PI 013-3 |
183 | PIC/S GUIDE TO INSPECTIONS OF SOURCE PLASMA ESTABLISHMENTS AND PLASMA WAREHOUSES (INSPECTION GUIDE) | 2007.09.25 | PIC/S | Guidance documents | 有 | PI 014-3 |
184 | STANDARD OPERATING PROCEDURE PIC/S INSPECTION REPORT FORMAT | 2007.09.25 | PIC/S | Inspectorates | 有 | PI 020-3 |
185 | AIDE MEMOIRE ON INSPECTION OF BIOTECH | 2007.09.25 | PIC/S | Aide-Memoires | 有 | PI 021-2 |
186 | AIDE MEMOIRE ON INSPECTION OF QUALITY CONTROL LABORATORIES | 2007.09.25 | PIC/S | Aide-Memoires | 有 | PI 023-2 |
187 | AIDE-MEMOIRE INSPECTION OF UTILITIES | 2007.09.25 | PIC/S | Aide-Memoires | 有 | PI 024-2 |
188 | AIDE-MEMOIRE ON MEDICINAL GASES | 2007.09.25 | PIC/S | Aide-Memoires | 有 | PI 025-2 |
189 | AIDE-MEMOIRE ON PACKAGING | 2009.01.13 | PIC/S | Aide-Memoires | 有 | PI 028-1 |
190 | AIDE-MEMOIRE ON THE INSPECTION OF APIS | 2009.01.13 | PIC/S | Aide-Memoires | 有 | PI 030-1 |
191 | RECOMMENDATION ON STERILITY TESTING | 2007.09.25 | PIC/S | Guidance documents | 有 | PI 031-1 |
192 | PIC/S RECOMMENDATION ON RISK-BASED INSPECTION PLANNING | 2012.01.01 | PIC/S | Guidance documents | 有 | PI 032-2 |
193 | EXPLANATORY NOTES FOR PHARMACEUTICAL MANUFACTURERS ON THE PREPARATION OF A SITE MASTER FILE | 2011.01.01 | PIC/S | Site Master Files | 有 | PI 038-1 |
194 | PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING FROM QUALITY DEFECTS | 2011.01.01 | PIC/S | Inspectorates | 有 | PI-037-1 |
195 | TECHNICAL INTERPRETATION OF REVISED ANNEX 1 TO PIC/S GMP GUIDE | 2010.01.08 | PIC/S | Guidance documents | 有 | PS INF 06 2012 (Rev 1) |
196 | VALIDATION MASTER PLAN INSTALLATION AND OPERATIONAL QUALIFICATION NON-STERILE PROCESS VALIDATION CLEANING VALIDATION | 2007.09.25 | PIC/S | Guidance documents | 有 | PS INF 20 2011 |
197 | STANDARD OPERATING PROCEDURE TEAM INSPECTIONS | 2009.07.29 | PIC/S | Inspectorates | 有 | PS W 01 2015 |
198 | SITE MASTER FILE FOR PLASMA WAREHOUSES | 2007.09.25 | PIC/S | PIC/S GMP Guide | 有 | PS/INF 21/2002 (Rev 18) |
199 | AIDE MEMOIRE ON ASSESSMENT OF QRM IMPLEMENTATION | 2012.03.26 | PIC/S | Aide-Memoires | 有 | |
200 | Bar Code Label Requirements
Questions and Answers | 2011.08 | FDA(CDER) | Compliance | 有 | PI 019-3 |
201 | COMPRESSED MEDICAL GASES | 1989.12.01 | FDA(CDER) | Compliance | 有 | Final |
202 | Computerized Systems Used in Clinical Investigations | 2007.05 | FDA(CDER) | Compliance | 有 | Final |
203 | Good Laboratory Practice Regulations Questions and Answers | 1981.06.01 | FDA(CDER) | Compliance | 有 | Final |
204 | Marketed Unapproved Drugs | 2011.09.19 | FDA(CDER) | Compliance | 有 | Final |
205 | Nuclear Pharmacy Guideline Criteria for Determining When to Register as a Drug Establishment | 1984.05.01 | FDA(CDER) | Compliance | 有 | Final |
206 | Part 11, Electronic Records; Electronic Signatures — Scope and Application | 2003.09.05 | FDA(CDER) | Compliance | 有 | Final |
207 | Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics | 2006.03.14 | FDA(CDER) | Compliance | 有 | Final |
208 | Prescription Drug Marketing Act (PDMA) Requirements | 2006 | FDA(CDER) | Compliance | 有 | Final |
209 | Review of FDA's Implementation of the Drug Export Amendments of 1986 | 1990.05.01 | FDA(CDER) | Compliance | 有 | |
210 | Street Drug Alternatives | 2000.04.03 | FDA(CDER) | Compliance | 有 | Final |
211 | 21CFR211Current Good Manufacturing Practice for Finished Pharmaceuticals | | FDA | 21 Code of Federal Regulations | 有 | Final |
212 | Comparability Protocols -- Protein Drug Products and Biological Products -- Chemistry, Manufacturing, and Controls Information | 2003.02.13 | FDA | CMC | 有 | Draft |
213 | Current Good Manufacturing Practice for Phase 1 Investigational Drugs | 2008.07.15 | FDA | Compliance | 有 | Final |
214 | Current Good Manufacturing Practices for Medical Gases | 2003.05.06 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
215 | Expiration Dating of Unit-Dose Repackaged Drugs: Compliance Policy Guide | 2005.05.31 | FDA | CGMP,Pharmaceutical Quality | 有 | |
216 | Formal Dispute Resolution_ Scientific and Technical Issues Related to Pharmaceutical CGMP | 2006.01.12 | FDA | Compliance | 有 | Draft |
217 | Good Laboratory Practice Regulations -- Questions and Answers | 1981.06.01 | FDA | Compliance | 有 | Final |
218 | guide to inspection of computerized systems in drug processing
药品生产中计算机处理系统的验证指南 | 1983 | FDA | | 有 | Final |
219 | Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality | 2013.06.25 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
220 | Immunogenicity-Related Considerations for the Approval of Low Molecular Weight Heparin for NDAs and ANDAs | 2014.04.09 | FDA | Compliance | 有 | Final |
221 | Interim Guidance for 3 Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act | | FDA | Compliance | 有 | Final |
222 | Investigating Out of Specification (OOS) Test Results for Pharmaceutical Production | 2006.10.12 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
223 | Marketed Unapproved Drugs;Compliance Policy Guide | 2011.09.19 | FDA | Compliance | 有 | Final |
224 | Part 11, Electronic Records, Electronic Signatures - Scope and Application | 2003.09.05 | FDA | Compliance | 有 | Final |
225 | Pharmaceutical Components at Risk for Melamine Contamination | 2009.08.07 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
226 | Possible Dioxin/PCB Contamination of Drug and Biological Products | 1999.08.23 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
227 | Preparation of Investigational New Drug Products (Human and Animal) | 1992.11.01 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
228 | Process Analytical Technology -- A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance | 2004.10.04 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
229 | Process Validation: General Principles and Practices
工艺验证:一般原则与规范 | 2011.01.25 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
230 | Pyrogen and Endotoxins Testing: Questions and Answers | 2012.06.28 | FDA | CGMP,Pharmaceutical Quality | 有 | Final |
231 | Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations | 2006.10.02 | FDA | CGMP,Pharmaceutical Quality | 有 | Draft |
232 | Sterile Drug Products Produced by Aseptic Processing | 2004.10.04 | FDA | CGMP,Pharmaceutical Quality | 有 | Draft |
233 | Testing of Glycerin for Diethylene Glycol | 2007.05.02 | FDA | CGMP,Pharmaceutical Quality | 有 | Draft |
234 | The Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 - Good Manufacturing Practice (CGMP) | 2010.01.27 | FDA | CGMP,Pharmaceutical Quality | 有 | |